Identifying and testing ADHD patients with a deficit in functional TACR1 gene and being treated with methylphenidate in the reverse-translated human 5C-CPT (Van Enkhuizen et al., 2013; Young et al., 2013a) would enable these hypotheses to be interrogated. The gene discussed is TACR1; the disease is attention deficit-hyperactivity disorder.